Edmond de Rothschild Investment Partners

Chase Pharmaceuticals Corporation secures $21 million in Series B round for improved Alzheimer drug clinical trials

Chase Pharmaceuticals Corporation raises $21 million in a Series B financing round led by New Rhein Healthcare Investors, LLC.

Read Full Article

Axonic Modulation Technologies secures $32.6M in Series A round

Axonics Modulation Technologies Inc has bagged $32.6 million for its Series A preferred stock financing round led by Edmond de Rothschild Investment Partners, a statement about the funding said.

Read Full Article

Edmond de Rothschild closes BioDiscovery 4 Fund

Edmond de Rothschild raises EUR192 million or USD250 million for its BioDiscovery 4 fund.

Read Full Article

Edmond de Rothschild leads Complix fundraiser

Complix completed its Series B funding as Edmond de Rothschild Investment Partners and GMIV handed their support.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics